ARZILENCE
PSYCHIATRY
Refer a Patient
New Patient Inquiry
Patient Portal
ARZIEd Academy Logo
Back to Classrooms

Borderline Personality Disorder

Understanding BPD: Emotional regulation, relationships, and evidence-based treatment

Overview of Borderline Personality Disorder

Borderline personality disorder (BPD) is characterized by instability in emotional regulation, interpersonal relationships, self-image, and impulse control, leading to recurrent mood disturbances, relationship difficulties, excessive risk-taking behaviors, and/or self-harm.

Prevalence

  • 1%-3% in the general population
  • 12% in outpatients receiving psychiatric services
  • 22% in psychiatric inpatient populations
  • Adolescents: 11% in outpatients, 33%-35% in inpatients

Risk Factors

  • Early or ongoing trauma or adverse experiences
  • Bullying, victimization, or peer relationship difficulties
  • History of abuse (emotional, physical, sexual) and/or neglect
  • Low socioeconomic status of family of origin
  • Hyperactivity in childhood
  • Disorganized attachment, maternal inconsistency, or parental substance misuse
  • Co-occurring Major Depressive Disorder or PTSD

Reference: Pediatrics 2014; BMJ 2013

Evaluation of Borderline Personality Disorder

BPD is a clinical diagnosis based on a persistent pattern of instability. A key task is to distinguish persistent "trait" characteristics from temporary "state" symptoms that might occur during a crisis or another mood episode.

DSM-5-TR Criteria (≥5 of the following)

  1. Frantic efforts to avoid abandonment
  2. Unstable and intense relationships (alternating idealization and devaluation)
  3. Unstable self-image or sense of self
  4. Impulsivity in at least two potentially self-damaging areas
  5. Recurrent suicidal behavior, gestures, threats, or self-mutilation
  6. Rapid mood changes (affective instability)
  7. Chronic feelings of emptiness
  8. Inappropriate, intense anger or difficulty controlling anger
  9. Transient, stress-related paranoid thoughts or severe dissociative symptoms

Reference: World Psychiatry 2022

Treatment Approaches

Psychotherapy is the primary treatment for BPD. While no medications are FDA-approved specifically for BPD, they may be used to manage co-occurring conditions or specific symptoms. A strong therapeutic alliance is fundamental to success.

Psychotherapy for BPD

Dialectical Behavior Therapy (DBT)

The most established treatment. Focuses on mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness.

Schema-Focused Therapy (SFT)

Addresses early maladaptive schemas (deep-seated life patterns) and helps patients develop healthier coping mechanisms.

Mentalization-Based Treatment (MBT)

Aims to improve the ability to mentalize—to understand one's own and others' mental states.

Transference-Focused Psychotherapy (TFP)

Uses the patient-therapist relationship to explore and work through the patient's internal world and relationship patterns.

Medications

Medications target specific symptom clusters rather than the disorder itself:

  • For cognitive-perceptual symptoms (e.g., paranoia): Low-dose antipsychotics may be used.
  • For impulsive-behavioral symptoms: Mood stabilizers (like lamotrigine) or omega-3 fatty acids may be considered.
  • For affective dysregulation (mood swings): Mood stabilizers or second-generation antipsychotics are sometimes used.

Antidepressants (SSRIs) are generally not effective for core BPD symptoms like emptiness or abandonment fears but can treat co-occurring depression. Benzodiazepines should be avoided due to risks of disinhibition and dependence.

Perinatal Considerations

During pregnancy and postpartum, BPD symptoms can improve for some but worsen for others. Psychotherapy remains the primary treatment. Medication management requires careful risk-benefit analysis with a specialist, as untreated maternal distress also poses risks to the fetus.